Repare Therapeutics Inc. Common Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
RPTX Company Description
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
RPTX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view RPTX Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of RPTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RPTX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of RPTX in WallStreetBets Daily Discussion
RPTX News
Recent insights relating to RPTX
CNBC Recommendations
Recent picks made for RPTX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in RPTX
Corporate Flights
Flights by private jets registered to RPTX
Our Analysis